ARHGEF38, an abbreviation for Rho Guanine Nucleotide Exchange Factor 38, is a protein that plays a pivotal role in cellular signaling, particularly in the regulation of the Rho family of GTPases. GTPases are known to control a multitude of cellular processes, including cell morphology, migration, endocytosis, and cell cycle progression. The primary function of ARHGEF38 is to facilitate the exchange of GDP for GTP on Rho proteins, thereby activating them. This activation initiates a cascade of intracellular events that lead to various cellular outcomes. Given the centrality of the Rho GTPases in cellular functions, the regulation and activation of these proteins, especially by proteins like ARHGEF38, are of paramount importance.
Activators of ARHGEF38 are molecules or compounds that can enhance or stimulate the function or expression of the ARHGEF38 protein. These activators can increase the protein's efficiency in facilitating GDP-GTP exchange on Rho GTPases or can promote greater expression or stability of ARHGEF38 within cells. The mechanisms through which these activators operate can be varied, ranging from directly binding to ARHGEF38 to altering its conformation for improved interaction with Rho proteins, to indirectly modulating its transcriptional or translational levels. By enhancing ARHGEF38's activity, these activators can profoundly influence the cellular landscape, particularly the intricate balance of Rho GTPase activation and the subsequent cellular responses. Understanding the dynamics and implications of ARHGEF38 activators can provide deeper insights into the sophisticated world of cellular signaling and the Rho GTPase-mediated cellular processes.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
By inhibiting prenylation of Rho family GTPases, Simvastatin might potentially induce a compensatory activation of ARHGEF38 expression to maintain Rho signaling pathway activity. |